Am. J. Respir. Crit. Care Med., Vol 151, No. 3, Mar 1995, 854-866.
SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains
JJ Coalson, RJ King, F Yang, V Winter, JA Whitsett, RA Delemos and SR Seidner
Department of Pathology, University of Texas Health Science Center at San Antonio.
The surfactant protein secretory cells in airway and alveolar epithelium
were studied in premature baboons with bronchopulmonary dysplasia and
superimposed infection. PRN animals were delivered by hysterotomy at 140 d
gestational age and ventilated on clinically appropriate oxygen for a 16-d
experimental period. To assess 0 time and sacrifice time gestational
parameters, 140 and 156 d were studied. BPD animals were delivered at 140 d
and ventilated with positive-pressure ventilation and an FIO2 of 1.0 for 11
d followed by 5 d of oxygen sufficient to maintain PAO2 at 40 to 50 mm Hg.
BPD-infected animals were comparably ventilated and treated like the BPD
group except that 10(8) E. coli organisms were endotracheally instilled on
Day 11. In situ hybridization studies for mRNA expression of SP-A, SP-B,
and SP-C revealed that an SP-A mRNA deficiency, present at 140 d, persisted
in the BPD and BPD-infected groups, whereas SP-A mRNA was abundant in PRN
and 156 d gestation control groups. SP-B and SP-C mRNA expression in the
two hyperoxically injured groups was particularly extensive in cells around
peribronchiolar and perivasicular sites. Immunostaining with SP-A, SP-B,
and SP-C antibodies showed variable staining patterns. The study clearly
demonstrates that a deficiency of SP-A mRNA expression persists in chronic
lung injury and that variable protein staining patterns are manifested
depending upon the underlying pathology.
This article has been cited by other articles:

|
 |

|
 |
 
D. McCurnin, S. Seidner, L.-Y. Chang, N. Waleh, M. Ikegami, J. Petershack, B. Yoder, L. Giavedoni, K. H. Albertine, M. J. Dahl, et al.
Ibuprofen-Induced Patent Ductus Arteriosus Closure: Physiologic, Histologic, and Biochemical Effects on the Premature Lung
Pediatrics,
May 1, 2008;
121(5):
945 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bry, J. A. Whitsett, and U. Lappalainen
IL-1beta Disrupts Postnatal Lung Morphogenesis in the Mouse
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
32 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ikegami, T. D. Le Cras, W. D. Hardie, M. T. Stahlman, J. A. Whitsett, and T. R. Korfhagen
TGF-{alpha} perturbs surfactant homeostasis in vivo
Am J Physiol Lung Cell Mol Physiol,
July 1, 2005;
289(1):
L34 - L43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
Am. J. Respir. Crit. Care Med.,
August 1, 2003;
168(3):
356 - 396.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. L. Chang, M. Subramaniam, B. A. Yoder, B. J. Day, M. C. Ellison, M. E. Sunday, and J. D. Crapo
A Catalytic Antioxidant Attenuates Alveolar Structural Remodeling in Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med.,
January 1, 2003;
167(1):
57 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Maniscalco, R. H. Watkins, M. A. O'Reilly, and C. P. Shea
Increased epithelial cell proliferation in very premature baboons with chronic lung disease
Am J Physiol Lung Cell Mol Physiol,
November 1, 2002;
283(5):
L991 - L1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. White, K. E. Greene, C. B. Allen, and J. M. Shannon
Elevated Expression of Surfactant Proteins in Newborn Rats during Adaptation to Hyperoxia
Am. J. Respir. Cell Mol. Biol.,
July 1, 2001;
25(1):
51 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. AWASTHI, J. J. COALSON, B. A. YODER, E. CROUCH, and R. J. KING
Deficiencies in Lung Surfactant Proteins A and D Are Associated with Lung Infection in Very Premature Neonatal Baboons
Am. J. Respir. Crit. Care Med.,
February 1, 2001;
163(2):
389 - 397.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. Glumoff, O. Väyrynen, T. Kangas, and M. Hallman
Degree of Lung Maturity Determines the Direction of the Interleukin-1- Induced Effect on the Expression of Surfactant Proteins
Am. J. Respir. Cell Mol. Biol.,
March 1, 2000;
22(3):
280 - 288.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. F. Allred, R. R. Mercer, R. F. Thomas, H. Deng, and R. L. Auten
Brief 95% O2 exposure effects on surfactant protein and mRNA in rat alveolar and bronchiolar epithelium
Am J Physiol Lung Cell Mol Physiol,
June 1, 1999;
276(6):
L999 - L1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. SEIDNER, A. H. JOBE, J. J. COALSON, and M. IKEGAMI
Abnormal Surfactant Metabolism and Function in Preterm Ventilated Baboons
Am. J. Respir. Crit. Care Med.,
December 1, 1998;
158(6):
1982 - 1989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Bachurski, S. E. Kelly, S. W. Glasser, and T. A. Currier
Nuclear Factor I Family Members Regulate the Transcription of Surfactant Protein-C
J. Biol. Chem.,
December 26, 1997;
272(52):
32759 - 32766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. T. Yuan, S. Gowan, F. J. Kelly, and C. D. Bingle
Cloning of guinea pig surfactant protein A defines a distinct cellular distribution pattern within the lung
Am J Physiol Lung Cell Mol Physiol,
October 1, 1997;
273(4):
L900 - L906.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|